Navigation Links
Cancer drugs in development nearly doubled since 1995

The number of drugs being developed for the treatment of cancer has nearly doubled during the past six years, according to a new survey of pharmaceutical companies. Currently, 170 pharmaceutical and biotechnology firms various Cancer Institutes are investigating 402 compounds for the treatment of various cancers, up from 215 in 1995. Many of the drugs are alternatives to standard radiation and chemotherapy. For lung cancer, the leading cause of cancer-related death in the United States, there are 68 drugs in the pipelines of various companies. Experimental drugs for the treatment of breast cancer total 59, while there are 55 for colon cancer, 52 for skin cancer and 52 for prostate cancer. Other cancers being targeted include solid tumors, sarcomas, pancreatic cancer, ovarian cancer, multiple myeloma, lymphoma, liver cancer, leukemia, kidney cancer, brain cancer, stomach cancer and bladder cancer. Of the drugs in development, 17 are waiting for Food and Drug Administration approval (FDA). Thanks in large part to medicines developed in the past decade, cancer deaths are on the decline. But cancer is still the second leading cause of American deaths by disease.
'"/>




Page: 1

Related medicine news :

1. Fibroids unlikely to Turn Cancerous
2. Virus Level could Predict Cervical Cancer Risk
3. Cancer Doctors Okays Controversial Prostate Therapy
4. Potential New Cancer Gene Identified
5. Consensus on "Combination Therapy" for Breast Cancer
6. Cancers of Colon & Rectum linked to Cigarette Smoking
7. Life Saving Cancer Drugs – From Chicken! Possible Says Dolly’ Creatos
8. The Cancer Rumour mill working over time
9. Radioactive Seeds used in Prostate Cancer treatment can migrate with the body
10. Cancer patients turning to Internet for information
11. ZD1839 Proves Effective - A Breakthrough in fighting Lung Cancer
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/14/2019)... ... May 14, 2019 , ... Relatient, Inc., a ... eRegistration and Check-In solution , a new product launched to reduce patient wait ... on Relatient’s Patient Engagement platform introducing earlier touch points on the ...
(Date:5/14/2019)... ... May 14, 2019 , ... A coalition ... the world’s biggest health issues – ‘big data’. At a news conference today, ... Research Centre), Stanford University and Southern Methodist University (SMU) announced the U.S. launch ...
(Date:5/14/2019)... ... May 14, 2019 , ... Forty-two billion dollars – just ... according to market analysis company Orbis Research. “Treatments certainly can help,” notes Angie ... PC , “but for our skin, there’s free super-potent anti-aging care available: It’s ...
(Date:5/14/2019)... ... May 14, 2019 , ... ChoiceSpine ... clearance from the U.S. Food and Drug Administration (FDA) to market TIGER SHARK ... a two-screw configuration, for use together or separately in cervical spinal fusion procedures. ...
(Date:5/14/2019)... YORK (PRWEB) , ... May 14, 2019 , ... Dr. ... for 20 years. Recently he acquired the FX 635 cold laser therapy device, becoming ... working on integrating this cutting edge laser with multiple FDA clearances for treating pain ...
Breaking Medicine News(10 mins):
(Date:5/16/2019)... ... 16, 2019 , ... Actuate Therapeutics, Inc., a clinical stage biopharmaceutical company, today ... Series B is led by Kairos Ventures, with DEFTA Partners, Tech Coast Angels, and ... to expand the company’s ongoing Phase 1 / 2 clinical trial and fund development ...
(Date:5/16/2019)... , ... May 16, 2019 , ... ... and Dr. Peter D. Caie, Senior Research Fellow at St. Andrew University, UK ... EDT (2pm BST/UK) to learn about a deep learning based image analysis solution ...
(Date:5/15/2019)... ... May 15, 2019 , ... E.M.M.A. ... compliance services for the Medical Device industry, will be participating in a panel ... growing digital device field. Also, EMMA International will be delivering a course on ...
Breaking Medicine Technology: